Grade Inflation?

The article on the University of Michigan's new organic chemistry course (The Scientist, Feb. 3, 1992, page 6) provoked in me something akin to an allergic reaction. Consider, for example, this quote: "Their approach seems to be working. In a class of nearly 1,000 students, nearly 75 percent earned an A or B.... Less than 1 percent failed; more significantly, only 2 percent dropped the course. In contrast, when professors grade students on a curve, the results are considerably fewer high grades

Written byJeffrey Bell
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

I'm not one who needs a weatherman to tell which way the wind is blowing. Next semester, I've decided to give everyone in my course an A. I'll be happier, the students will be happier, and my university will be recognized for another innovative contribution to science education.

Can't we find a more reliable measure of accomplishment than grade inflation? I am not questioning the sincerity or teaching ability of the organizers of this course, which I guess to be very high. Instead, I am asking the fundamental questions: Do we have any evidence that their ideas are working? Did the students learn anything? The article says plenty about hopes and beliefs, but nothing about controls, analysis, and experimental design in the evaluation of this program.

Apparently some evidence shows that a problem exists in undergraduate science education. Solutions that look splendid at first glance are abundant, but how will ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies